Eswatini vs Ghana: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Eswatini
1.2%
in 2024
Ghana
1.1%
in 2024
Eswatini rank
25th
Ghana rank
26th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Eswatini
- Ghana
How they compare
Eswatini currently reports 1.2% against 1.1% in Ghana, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Ghana's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Ghana ahead.
Eswatini ranks 25th and Ghana ranks 26th of 215 countries.
Across the 2 decades both report, Eswatini averaged higher in 1 and Ghana in 1.
Head to head by decade
| Decade | Eswatini | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.7% | 0.2% | Ghana |
| 2020s | 1.4% | 1.2% | 0.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Eswatini or Ghana?
- Eswatini, at 1.2% against 1.1% in Ghana as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Eswatini and Ghana?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Ghana?
- 10 years are reported by both, from 2015 to 2024.
- How do Eswatini and Ghana rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Eswatini ranks 25th and Ghana ranks 26th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.